Complement activation in patients with COVID-19: A novel therapeutic target
- PMID: 32417135
- PMCID: PMC7224678
- DOI: 10.1016/j.jaci.2020.05.006
Complement activation in patients with COVID-19: A novel therapeutic target
Figures
References
-
- Riedl M., Fakhouri F., Le Quintrec M., Noone D.G., Jungraithmayr T.C., Fremeaux-Bacchi V. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost. 2014;40:444–464. - PubMed
-
- Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection [published online ahead of print April 10, 2020]. medRxiv. 10.1101/2020.03.04.20031120. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
